<DOC>
	<DOCNO>NCT00391547</DOCNO>
	<brief_summary>The primary purpose demonstrate efficacy prescription mouthrinse human subject treatment Gingivitis .</brief_summary>
	<brief_title>Pilot Efficacy Study Treat Gingivitis</brief_title>
	<detailed_description>Gingivitis endemic disease precursor periodontal disease . Two mouthrinse agent , Peridex Listerine , receive Seal Acceptance Council Dental Therapeutics American Dental Association control supragingival plaque gingivitis . Peridex ( 0.12 % chlorhexidine , bisbiguanide cationic detergent ) prescription mouthrinse demonstrate potent anti-plaque anti-gingivitis action . Chlorhexidine rinse also prescribed prevent post surgical infection . Chlorhexidine broad spectrum antibacterial activity substantivity . With prolonged use , chlorhexidine maintains effectiveness cause stain natural teeth composite material use restorative dentistry . Other side effect associate chlorhexidine calculus formation possible alteration taste . Although chlorhexidine rinse supragingival irrigation demonstrate significant efficacy reduce plaque gingivitis , chlorhexidine minimal impact treat periodontal disease . Listerine , comprise essential oil , over-the-counter mouthrinse less effective chlorhexidine control plaque gingivitis , minimal side effect . Other agent quaternary ammonium compound metal salt rarely use alone used combination antimicrobial rinse enhance effectiveness .</detailed_description>
	<mesh_term>Gingivitis</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<criteria>Subjects shall meet follow inclusion criterion eligible participation study : Males nonpregnant females 18 year age , good general health , determine Investigator . Have 16 natural , gradable teeth good dental health , determine Investigator . Have &gt; 25 % site GI score &gt; 2 . Have average PI score &gt; 2 . Use effective method contraception duration study permanently sterilize . Able willing comply study requirement include follow instruction study treatment ( drug ) return followup visit require protocol . Have full understanding element , signature date write informed consent prior initiation protocol specify procedure . Females childbearing potential must negative pregnancy test study period . Sexually active female must use effective form birth control . These method include oral contraceptive ( `` pill '' ) , intrauterine device ( IUD ) , levonogestrol implant ( Norplant® ) , medroxyprogesterone acetate injection ( Depoprovera® ) contraceptive foam condom . Subjects meet follow exclusion criterion eligible participation study : History , current evidence , significant acute chronic medical psychiatric condition , opinion Investigator , would render examination difficult invalid prevent subject active study participation . Treatment antibiotic within one ( 1 ) month period prior screen examination . Presence heart murmur , history rheumatic fever , valvular disease prosthetic implant require antibiotic premedication . History thyroid disease . Known sensitivity allergy iodine . Known sensitivity allergy shellfish . History diabetes . History autoimmune disease . Gross oral pathology ( periodontal disease , rampant caries , tissue damage create poor oral care treatment , soft hard tissue tumor ) , opinion Investigator , could influence outcome study . Current sign symptom mucosal tissue ulceration inflammation , canker sore . Presence orthodontic appliance removable appliance impinges oral tissue assess . History early onset periodontal disease acute necrotizing ulcerative gingivitis . History current alcohol abuse , opinion Investigator , could influence outcome study . History , current drug abuse . Use concomitant medication , opinion Investigator , might interfere outcome study ( e.g . antibiotic , immunosuppressant , steroid , therapeutic dos nonsteroidal antiinflammatory agent , phenytoin , calcium antagonist , cyclosporine coumadin ) . Concomitant therapy another investigational drug device without prior approval Sponsor within four ( 4 ) week prior Visit 2 ( Study Day 1 ) . Concomitant endodontic periodontal therapy prophylaxis past six ( 6 ) month . Females childbearing potential positive pregnancy test , pregnant nursing mother , suspected pregnancy , intention become pregnant study . Unable unwilling comply informed consent process , meet study requirement include follow instruction study treatment ( drug ) , return followup visit require protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Gingivitis Disease</keyword>
</DOC>